| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/27/2010 | WO2010031712A3 Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (tesi) |
| 05/27/2010 | WO2010030171A8 Method for diagnostic marker development |
| 05/27/2010 | WO2010028214A3 Screening method to identify molecules having the ability to modulate the activity of a catalyst |
| 05/27/2010 | WO2010027977A3 Colorimetric bioassay for perchlorate |
| 05/27/2010 | WO2010022289A3 Methods for removal of specific seed tissue or structure for seed analysis |
| 05/27/2010 | WO2010022166A3 Micro rna and neurofibromatosis type 1 in diagnosis and therapy |
| 05/27/2010 | WO2010021872A3 Enhancing endotoxin detection |
| 05/27/2010 | WO2010019519A3 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity |
| 05/27/2010 | WO2010011358A3 Method and medium for detecting the presence or absence of staphylococcus aureus in a test sample |
| 05/27/2010 | WO2010009377A3 Methods and compositions for pharmacogenetic analysis of anti-inflammatory drugs in the treatment of rheumatoid arthritis and other inflammatory diseases |
| 05/27/2010 | WO2010008543A9 Molecular signatures for diagnosing scleroderma |
| 05/27/2010 | WO2010000591A3 Fluorescent cyclic peptides, methods for the preparation thereof, and use of said peptides for measuring the enzymatic activity of a protease enzyme |
| 05/27/2010 | WO2009148616A3 Systems and methods for determining properties that affect an expression property value of polynucleotides in an expression system |
| 05/27/2010 | WO2009114712A3 Assays for diagnosing and evaluating treatment options for pompe disease |
| 05/27/2010 | WO2009114681A3 Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy |
| 05/27/2010 | WO2009104075A3 Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore and other sandwich assays |
| 05/27/2010 | US20100132076 Fluid Delivery for Scanning Probe Microscopy |
| 05/27/2010 | US20100132069 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants |
| 05/27/2010 | US20100132067 Marker mapping and resistance gene associations in soybean |
| 05/27/2010 | US20100132062 Rice Mutant Allele |
| 05/27/2010 | US20100132058 Methods and materials for determining pain sensitivity and predicting and treating related disorders |
| 05/27/2010 | US20100132056 Germ Cell Marker Using Fish Vasa Gene |
| 05/27/2010 | US20100132055 Animal model for the selection and validation of agents active against pulmonary emphysema and colorectal cancer |
| 05/27/2010 | US20100131432 Methods and compositions of molecular profiling for disease diagnostics |
| 05/27/2010 | US20100131286 Methods for the prognosis or for the diagnosis of a thyroid disease |
| 05/27/2010 | US20100131285 Actn3 genotype screen for athletic performance |
| 05/27/2010 | US20100130733 Luminescent metal ion complexes |
| 05/27/2010 | US20100130720 Artificial binding proteins based on a modified alpha helical region of ubiquitin |
| 05/27/2010 | US20100130600 Lipoprotein lipase and its effect on statin treatments |
| 05/27/2010 | US20100130599 CYP2C9*8 Alleles Correlate With Decreased Warfarin Metabolism And Increased Warfarin Sensitivity |
| 05/27/2010 | US20100130590 Deletion bearing bard1 isoforms and use thereof |
| 05/27/2010 | US20100130586 Diagnosis and treatment of t-cell acute lymphoblastic leukemia |
| 05/27/2010 | US20100130585 Methods and compositions for investigation and treatment of cancer using a g-protein coupled eicosanoid receptor |
| 05/27/2010 | US20100130579 Cancer therapy |
| 05/27/2010 | US20100130547 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide |
| 05/27/2010 | US20100130527 Individualized cancer treatment |
| 05/27/2010 | US20100130526 Methods for Disease Therapy |
| 05/27/2010 | US20100130498 Agonists of bitter taste receptors and uses thereof |
| 05/27/2010 | US20100130489 Imidazolo-heteroaryl derivatives with antibacterial properties |
| 05/27/2010 | US20100130450 Methods of Treating Fungal Infections |
| 05/27/2010 | US20100130439 Genomic mutation inhibitors that inhibit y family dna polymerases |
| 05/27/2010 | US20100130432 Non-Natural Amino Acids and Neurotensin Analogues Thereof |
| 05/27/2010 | US20100130429 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome |
| 05/27/2010 | US20100130421 Biomodulators for treatment or prevention of disease |
| 05/27/2010 | US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor |
| 05/27/2010 | US20100130403 Biomarkers for insulin efficacy |
| 05/27/2010 | US20100130381 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections |
| 05/27/2010 | US20100130377 Predicting cancer outcome |
| 05/27/2010 | US20100130374 High-throughput diagnostic testing using arrays |
| 05/27/2010 | US20100130371 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 05/27/2010 | US20100130367 Methods of Quantitatively Assessing Inflammation with Biosensing Nanoparticles |
| 05/27/2010 | US20100129896 System for differentiating the lengths of nucleic acids of interest in a sample |
| 05/27/2010 | US20100129876 Pasting Edge Heater |
| 05/27/2010 | US20100129871 Pyrophosphorolysis activated polymerization (pap) |
| 05/27/2010 | US20100129868 Delta 4,5 glycuronidase compositions and methods related thereto |
| 05/27/2010 | US20100129858 Method for separation, characterization and/or identification of microorganisms using spectroscopy |
| 05/27/2010 | US20100129857 Methods for the isolation and identification of microorganisms |
| 05/27/2010 | US20100129856 Methods and Devices for Cell Signaling Under Pulse Stimulation |
| 05/27/2010 | US20100129855 Blood cell analyzer, blood cell analyzing method, and computer program product |
| 05/27/2010 | US20100129854 Liver cell toxicity assay |
| 05/27/2010 | US20100129853 Disease markers |
| 05/27/2010 | US20100129852 Integrated Bioanalyzer |
| 05/27/2010 | US20100129851 Methods of diagnosing muscle damage |
| 05/27/2010 | US20100129850 Method for analyzing the effect of a gaseous medium on a biological test system using an extracellular metabolization system and a device for carrying out the method |
| 05/27/2010 | US20100129849 Cell observation apparatus, cell observation method, and program |
| 05/27/2010 | US20100129848 Rapid Mixing Device for Subsecond Analysis of Cell Surface Kinetics in Flow Cytometry |
| 05/27/2010 | US20100129847 Method for the detection of amyloid-b oligomers in body fluids |
| 05/27/2010 | US20100129846 Isoform specificities of blood serum proteins and their use as differentially expressed protein biomarkers for diagnosis of breast cancer |
| 05/27/2010 | US20100129845 Astaxanthine Biosynthesis in Eukaryotes |
| 05/27/2010 | US20100129844 Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer |
| 05/27/2010 | US20100129843 Characterization of n-glycans using exoglycosidases |
| 05/27/2010 | US20100129842 Isobarically labeled analytes and fragment ions derived therefrom |
| 05/27/2010 | US20100129841 Detection of a blood coagulation activity marker in a body fluid sample |
| 05/27/2010 | US20100129840 Method and Apparatus for Reducing Luminescent Test Result Interferences |
| 05/27/2010 | US20100129827 Method and device for sample preparation control |
| 05/27/2010 | US20100129826 Double stranded RNA receptor (dsRNA-R) and methods relating thereto |
| 05/27/2010 | US20100129825 Method for the detection of bacterial species of the genera anaplasma/ehrlichia and bartonella |
| 05/27/2010 | US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 05/27/2010 | US20100129823 Methods for identifying subjects susceptible to ataxic neurological disease |
| 05/27/2010 | US20100129822 Compositions and methods for detecting small rnas, and uses thereof |
| 05/27/2010 | US20100129821 Broad range pcr-based compositions and methods for the detection and identification of fungal pathogens |
| 05/27/2010 | US20100129820 Strongly quenching oligomeric excimer/quencher pairs for detection schemes |
| 05/27/2010 | US20100129819 Methods and compositions in particle-based detection of target molecules using linking molecules |
| 05/27/2010 | US20100129818 Polymorphisms in Genes Affecting CYP2C9-Related Disorders and Uses Thereof |
| 05/27/2010 | US20100129817 Identifying germline competent embryonic stem cells |
| 05/27/2010 | US20100129816 Microbial Population Analysis |
| 05/27/2010 | US20100129815 Identification of cardiac specific myosin light chain kinase |
| 05/27/2010 | US20100129814 Method for separation and characterization of microorganisms using identifier agents |
| 05/27/2010 | US20100129813 Compositions and methods for detecting food-borne pathogens |
| 05/27/2010 | US20100129812 Nucleic acid hybridization essay method |
| 05/27/2010 | US20100129811 Compositions for use in identification of pseudomonas aeruginosa |
| 05/27/2010 | US20100129810 Methods and systems for nucleic acid sequencing validation, calibration and normalization |
| 05/27/2010 | US20100129809 INHIBITORS OF Rv0256c |
| 05/27/2010 | US20100129808 Particles for detecting intracellular targets |
| 05/27/2010 | US20100129807 Stabilization of cyclic peptide structures |
| 05/27/2010 | US20100129806 Regulation of cell survival by hsp90 and ip6k2 |
| 05/27/2010 | US20100129805 Slc1a1 antipsychotic drug response markers |
| 05/27/2010 | US20100129804 Spink1 as a prostate cancer marker and uses thereof |
| 05/27/2010 | US20100129803 Method for determining dna fragmentation in microorganisms |
| 05/27/2010 | US20100129802 Method of Sequencing a Genome |